美中嘉和 02453Prospectus Information

Prospectus Information
返回 Stock Info Prospectus Allotment Results Allotment Profile Expected Lots
IPO Timeline
Broker Results (T-2)
2024-01-05
Some brokers release in afternoon
Grey Market (T-1)
2024-01-08
Afternoon
HKEX Allotment (T-1)
2024-01-08
Evening
Registrar Allotment (T-1)
2024-01-08
Evening
Listing Day (T)
2024-01-09
First day of trading
Company Overview
Stock Name美中嘉和
Stock Code02453
Company Full Name美中嘉和
Industry醫療保健
Principal Activities公司為中國一家腫瘤醫療服務提供商，為癌癥患者及第三方醫療機構提供服務。
Listing Date2024-01-09
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國北京市朝陽區光華路7號漢威大廈東區26A1–26A5室
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehttps://www.concordmedical.com/
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo data
Offering Information
Offering Mechanism To be extracted
Offer PriceHK$ 14.28 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer PeriodTo be extracted
Global Offering SharesTo be extracted
HK Public Offer Shares (Initial)To be extracted
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)To be extracted
Offer RatioTo be extracted
Total Shares Post-IPOTo be extracted
Greenshoe (Over-allotment Option)To be confirmed
Stabilizing Manager (Greenshoe)—
Cornerstone Share0%
Clawback TiersTo be extracted
Reallocation OptionTo be confirmed
Total Global Offering SizeHK$ 56,294,616
Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 400,000 HK$ 5,712,000
4 lots 1,971,000 HK$ 28,145,880
Valuation & Financials
Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)To be extracted
P/E RatioTo be extracted
Profit/Loss StatusTo be extracted
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted
First Day Performance
First Day CloseHK$ 11.08
First Day OpenHK$ 9.8
First Day Change-22.41%
First Day Volume3770200.0
First Day Turnover40455200.0
Use of Proceeds
Use of Proceeds1、約59.4%（即299.0百萬港元）用于償還部分計息銀行貸款； 2、約30.6%（即153.7百萬港元）用于為上海醫院的籌建提供資金，預計其將于2026年1月開始運營； 3、約10.0%（即50.3百萬港元）用作營運資金及其他一般公司用途。
Underwriting Syndicate
Joint Sponsors (2)
中国国际金融香港证券有限公司 CE AEN894 海通国际资本有限公司 CE ADQ859
Overall Coordinators (4)
中国国际金融香港证券有限公司 CE AEN894 海通国际证券有限公司 CE AAF806 中信里昂证券有限公司 CE AAB893 浦银国际融资有限公司 CE BFZ375
Joint Bookrunners (14)
中国国际金融香港证券有限公司 CE AEN894 海通国际证券有限公司 CE AAF806 中信里昂证券有限公司 CE AAB893 浦银国际融资有限公司 CE BFZ375 农银国际证券有限公司 CE ACX411 建银国际金融有限公司 CE AJO225 中国光大证券（香港）有限公司 CE AAW536 招银国际融资有限公司 CE AVM940 复星国际证券有限公司 CE AAF432 富途证券国际（香港）有限公司 CE AZT137 利弗莫尔证券有限公司 CE BJN764 MOUETTE SECURITIES COMPANY LIMITED CE BLE877 华盛资本证券有限公司 CE AUL711 老虎证券（香港）环球有限公司 CE BMU940
Joint Lead Managers (14)
中国国际金融香港证券有限公司 CE AEN894 海通国际证券有限公司 CE AAF806 中信里昂证券有限公司 CE AAB893 浦银国际融资有限公司 CE BFZ375 农银国际证券有限公司 CE ACX411 建银国际金融有限公司 CE AJO225 中国光大证券（香港）有限公司 CE AAW536 招银国际融资有限公司 CE AVM940 复星国际证券有限公司 CE AAF432 富途证券国际（香港）有限公司 CE AZT137 利弗莫尔证券有限公司 CE BJN764 MOUETTE SECURITIES COMPANY LIMITED CE BLE877 华盛资本证券有限公司 CE AUL711 老虎证券（香港）环球有限公司 CE BMU940
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
Chairman楊建宇
Company Secretary潘立臣;何詠雅
No director data available.
Major Shareholders
Major Shareholders & Holdings醫學之星(上海)融資租賃有限公司(26.84%);中金佳泰貳期(天津)股權投資基金合伙企業(有限合伙)(16.75%);寧波信鈺嘉慧企業管理有限公司(10.86%);北京泰和誠醫療技術有限公司(9.55%)
AI AI Analysis
!
The following content is generated by an AI model based on historical IPO data. It does NOT constitute investment advice, solicitation, or recommendation. Past subscription patterns and post-listing performance do not guarantee future results. Data may contain inaccuracies — always verify against official HKEX filings and prospectuses before making any investment decision.

Market Sentiment

The IPO recorded a modest oversubscription ratio of 1.99 times, with a 100% hit rate indicating all applicants received full allocations. This lack of competitive demand suggests tepid market enthusiasm. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Tier Analysis

No tier-level subscription data is available, making anomaly analysis impossible. With a 100% hit rate, allocation is uniform across all applicant sizes, obviating any tier-based efficiency concerns. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Demographics

Demographic data shows zero registered holders, which likely indicates incomplete reporting or a dispersed retail base. No patterns regarding mainland participation, gender, or age distribution can be discerned. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

AI-generated content. For informational purposes only. Not financial advice. Verify against official sources.
IPO Timeline
Disclaimer & Risk Warning

Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.

Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.

Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.

Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.

Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.

Cibo — IPO & Market Data Analytics